SMAD9 and myeloid leukemia: ASB2, a newly identified E3 ligase of SMAD9, was originally identified as a retinoic acid-inducible protein in myeloid leukaemia cells in which Asb2 is regulated by PML-RARα, a pathological gene sequence generated because of translocation t(15;17)43.